CD8A and breast cancer: Furthermore, in obese mice with spontaneous onset of mammary tumors, ablation of T-cell STAT3, or treatment with FAO inhibitors, reduced FAO to increase glycolysis and CD8+ T effector cell function, thereby inhibiting mammary tumor development [77].